185 related articles for article (PubMed ID: 15893708)
1. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708
[TBL] [Abstract][Full Text] [Related]
2. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
[TBL] [Abstract][Full Text] [Related]
3.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
4. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
Reinhardt MJ; Jüngling FD; Krause TM; Braune S
Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
[TBL] [Abstract][Full Text] [Related]
7. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
[TBL] [Abstract][Full Text] [Related]
8. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
11. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
Lee PH; Yeo SH; Kim HJ; Youm HY
Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
[TBL] [Abstract][Full Text] [Related]
12. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
13. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
[TBL] [Abstract][Full Text] [Related]
14. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
15. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
[TBL] [Abstract][Full Text] [Related]
17. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
[TBL] [Abstract][Full Text] [Related]
18. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
[TBL] [Abstract][Full Text] [Related]
19. MIBG scintigraphy of the major salivary glands in multiple system atrophy.
Soboll L; Leppert D; Dillmann U; Schaefer-Schuler A; Fassbender K; Ezziddin S; Spiegel J
Parkinsonism Relat Disord; 2018 Aug; 53():112-114. PubMed ID: 29752191
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
Nagayama H; Ueda M; Yamazaki M; Nishiyama Y; Hamamoto M; Katayama Y
Mov Disord; 2010 Aug; 25(11):1744-7. PubMed ID: 20645402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
